Skip to content

Pilot-testing of the Japanese version of EORTC QLQ-INFO25

Pilot-testing of the Japanese version of EORTC QLQ-INFO25 - Pilot-testing of the Japanese version of EORTC QLQ-INFO25

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020035
Enrollment
15
Registered
2015-12-02
Start date
2015-12-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

None listed

Sponsors

Tohoku University Graduate School of Medicine, Division of Biostatistics
Lead Sponsor
Keiyu Hospital Tokyo Medical University Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Diagnosed with cancer and receiving cancer medication. 2.Receiving the information about medication. 3.Native Japanese speaker

Exclusion criteria

Exclusion criteria: 1. Double cancer 2. Severe psychiatric disorder 3. Linguistic difficulty preventing patients from completing the questionnaires.

Design outcomes

Primary

MeasureTime frame
The primary outcomes associated with this study include the ability for the EORTC QLQ-INFO25 to be used in Japan with confidence that the Japanese items are translated correctly and are culturally meaningful and appropriate.

Countries

Japan

Contacts

Public ContactTakashi Kawaguchi

Tokyo University of Pharmacy and Life Sciences Department of Practical Pharmacy

tkawa@toyaku.ac.jp042-676-1521

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026